Viewing Study NCT06761560


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-01 @ 5:53 AM
Study NCT ID: NCT06761560
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-07
First Post: 2024-12-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia
Sponsor: Yves Pastore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease (SCD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hydroxyurea View
None pharmacokinetic View
None sickle cell disease View